BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 26736068)

  • 1. Quantitative Secretomic Analysis Identifies Extracellular Protein Factors That Modulate the Metastatic Phenotype of Non-Small Cell Lung Cancer.
    Hu R; Huffman KE; Chu M; Zhang Y; Minna JD; Yu Y
    J Proteome Res; 2016 Feb; 15(2):477-86. PubMed ID: 26736068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miRNA and Proteomic Dysregulation in Non-Small Cell Lung Cancer in Response to Cigarette Smoke.
    Babu N; Advani J; Solanki HS; Patel K; Jain A; Khan AA; Radhakrishnan A; Sahasrabuddhe NA; Mathur PP; Nair B; Keshava Prasad TS; Chang X; Sidransky D; Gowda H; Chatterjee A
    Microrna; 2018; 7(1):38-53. PubMed ID: 29299995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L1 cell adhesion molecule promotes tumorigenicity and metastatic potential in non-small cell lung cancer.
    Hai J; Zhu CQ; Bandarchi B; Wang YH; Navab R; Shepherd FA; Jurisica I; Tsao MS
    Clin Cancer Res; 2012 Apr; 18(7):1914-24. PubMed ID: 22307136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alpha-enolase promotes cell glycolysis, growth, migration, and invasion in non-small cell lung cancer through FAK-mediated PI3K/AKT pathway.
    Fu QF; Liu Y; Fan Y; Hua SN; Qu HY; Dong SW; Li RL; Zhao MY; Zhen Y; Yu XL; Chen YY; Luo RC; Li R; Li LB; Deng XJ; Fang WY; Liu Z; Song X
    J Hematol Oncol; 2015 Mar; 8():22. PubMed ID: 25887760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWATH™- and iTRAQ-based quantitative proteomic analyses reveal an overexpression and biological relevance of CD109 in advanced NSCLC.
    Zhang F; Lin H; Gu A; Li J; Liu L; Yu T; Cui Y; Deng W; Yan M; Li J; Yao M
    J Proteomics; 2014 May; 102():125-36. PubMed ID: 24667143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cancer secretome, current status and opportunities in the lung, breast and colorectal cancer context.
    Schaaij-Visser TB; de Wit M; Lam SW; Jiménez CR
    Biochim Biophys Acta; 2013 Nov; 1834(11):2242-58. PubMed ID: 23376433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased expression of the lncRNA PVT1 promotes tumorigenesis in non-small cell lung cancer.
    Yang YR; Zang SZ; Zhong CL; Li YX; Zhao SS; Feng XJ
    Int J Clin Exp Pathol; 2014; 7(10):6929-35. PubMed ID: 25400777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Over-expression of Orai1 mediates cell proliferation and associates with poor prognosis in human non-small cell lung carcinoma.
    Zhan ZY; Zhong LX; Feng M; Wang JF; Liu DB; Xiong JP
    Int J Clin Exp Pathol; 2015; 8(5):5080-8. PubMed ID: 26191202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proteomic analysis identifies CPNE3 as a novel metastasis-promoting gene in NSCLC.
    Lin HC; Zhang FL; Geng Q; Yu T; Cui YQ; Liu XH; Li J; Yan MX; Liu L; He XH; Li JJ; Yao M
    J Proteome Res; 2013 Jul; 12(7):3423-33. PubMed ID: 23713811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unique Protein Profiles of Extracellular Vesicles as Diagnostic Biomarkers for Early and Advanced Non-Small Cell Lung Cancer.
    An T; Qin S; Sun D; Huang Y; Hu Y; Li S; Zhang H; Li B; Situ B; Lie L; Wu Y; Zheng L
    Proteomics; 2019 Jun; 19(12):e1800160. PubMed ID: 30950185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testicular orphan receptor 4 (TR4) is a marker for metastasis and poor prognosis in non-small cell lung cancer that drives the EMT phenotype.
    Zhang L; Zhang J; Ma Y; Chen J; Dong B; Zhao W; Wang X; Zheng Q; Fang F; Yang Y
    Lung Cancer; 2015 Sep; 89(3):320-8. PubMed ID: 26144287
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A high-quality secretome of A549 cells aided the discovery of C4b-binding protein as a novel serum biomarker for non-small cell lung cancer.
    Luo X; Liu Y; Wang R; Hu H; Zeng R; Chen H
    J Proteomics; 2011 Apr; 74(4):528-38. PubMed ID: 21262398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of adenylate cyclase-associated protein 1 is associated with metastasis of lung cancer.
    Tan M; Song X; Zhang G; Peng A; Li X; Li M; Liu Y; Wang C
    Oncol Rep; 2013 Oct; 30(4):1639-44. PubMed ID: 23842884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of microRNA-21 expression restrains non-small cell lung cancer cell proliferation and migration through upregulation of programmed cell death 4.
    Yang Y; Meng H; Peng Q; Yang X; Gan R; Zhao L; Chen Z; Lu J; Meng QH
    Cancer Gene Ther; 2015 Jan; 22(1):23-9. PubMed ID: 25477028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. S100 family members and trypsinogens are predictors of distant metastasis and survival in early-stage non-small cell lung cancer.
    Diederichs S; Bulk E; Steffen B; Ji P; Tickenbrock L; Lang K; Zänker KS; Metzger R; Schneider PM; Gerke V; Thomas M; Berdel WE; Serve H; Müller-Tidow C
    Cancer Res; 2004 Aug; 64(16):5564-9. PubMed ID: 15313892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer.
    Li P; Li J; Yang R; Zhang F; Wang H; Chu H; Lu Y; Dun S; Wang Y; Zang W; Du Y; Chen X; Zhao G; Zhang G
    Diagn Pathol; 2015 Jun; 10():63. PubMed ID: 26055877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The long noncoding MALAT-1 RNA indicates a poor prognosis in non-small cell lung cancer and induces migration and tumor growth.
    Schmidt LH; Spieker T; Koschmieder S; Schäffers S; Humberg J; Jungen D; Bulk E; Hascher A; Wittmer D; Marra A; Hillejan L; Wiebe K; Berdel WE; Wiewrodt R; Muller-Tidow C
    J Thorac Oncol; 2011 Dec; 6(12):1984-92. PubMed ID: 22088988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of five candidate lung cancer biomarkers by proteomics analysis of conditioned media of four lung cancer cell lines.
    Planque C; Kulasingam V; Smith CR; Reckamp K; Goodglick L; Diamandis EP
    Mol Cell Proteomics; 2009 Dec; 8(12):2746-58. PubMed ID: 19776420
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of RON in small and non-small cell lung cancers.
    Kanteti R; Krishnaswamy S; Catenacci D; Tan YH; EL-Hashani E; Cervantes G; Husain AN; Tretiakova M; Vokes EE; Huet H; Salgia R
    Genes Chromosomes Cancer; 2012 Sep; 51(9):841-51. PubMed ID: 22585712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteome analysis of non-small cell lung cancer cell line secretomes and patient sputum reveals biofluid biomarker candidates for cisplatin response prediction.
    Böttger F; Schaaij-Visser TB; de Reus I; Piersma SR; Pham TV; Nagel R; Brakenhoff RH; Thunnissen E; Smit EF; Jimenez CR
    J Proteomics; 2019 Mar; 196():106-119. PubMed ID: 30710758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.